Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.

Medullary thyroid carcinoma (MTC) is a neuroendocrine (NE) malignancy that frequently metastasizes and has limited treatments. We recently reported that ectopic expression of Notch-1 in human MTC cells suppresses growth. The objective of this study was to evaluate the ability of suberoyl bis-hydroxamic acid (SBHA) to modulate Notch-1 signaling in MTC cells. At baseline, no active Notch-1 protein was present in MTC cells. Treatment with SBHA resulted in a dose-dependent induction of the Notch-1 intracellular domain, the active form of the protein. Furthermore, with Notch-1 activation there was a concomitant decrease in achaete-scute complex-like 1 (ASCL-1), a downstream target of Notch-1 signaling, as well as the NE tumor marker chromogranin A (CgA). Transfection of Notch-1 small-interfering RNA into MTC cells blocked the effects of SBHA on Notch-1 activation, ASCL-1, and CgA. Importantly, SBHA treatment resulted in a dose-dependent decrease in cell viability. Treated cells had an increase in protein levels of cleaved caspase-3 and poly ADP-ribose polymerase, and changes in the expression of apoptotic mediators including Bcl-X(L) and Bad, indicating that the growth inhibition was a result of apoptosis. These results demonstrate that SBHA activates Notch-1 signaling, which is associated with the antiproliferative and apoptotic effects in MTC cells. Therefore, Notch-1 activation with SBHA is an attractive new strategy for the treatment of patients with MTC.

[1]  D. Ball.  Medullary thyroid cancer: monitoring and therapy. , 2007, Endocrinology and metabolism clinics of North America.

[2]  Herb Chen,et al.  Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. , 2007, The oncologist.

[3]  C. Benbassat,et al.  Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. , 2007, Thyroid : official journal of the American Thyroid Association.

[4]  Herb Chen,et al.  Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. , 2007, The oncologist.

[5]  Victoria Bolós,et al.  Notch signaling in development and cancer. , 2007, Endocrine reviews.

[6]  T. Park,et al.  Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation , 2007, Cell Death and Differentiation.

[7]  Herb Chen,et al.  Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer. , 2007, Asian journal of surgery.

[8]  J. Aster,et al.  The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.

[9]  Herb Chen,et al.  Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells* , 2006, Journal of Biological Chemistry.

[10]  Herb Chen,et al.  Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. , 2006, Surgery.

[11]  P. Hersey,et al.  Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells , 2006, Apoptosis.

[12]  I. Rooman,et al.  Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. , 2006, The American journal of pathology.

[13]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[14]  Herb Chen,et al.  Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. , 2005, Surgery.

[15]  R. Soldi,et al.  The intracellular domain of Notch ligand Delta1 induces cell growth arrest , 2005, FEBS letters.

[16]  Herb Chen,et al.  Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[17]  Yu-fang Cui,et al.  Pathways to caspase activation , 2005, Cell biology international.

[18]  E. Nakakura,et al.  Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  C. Manetopoulos,et al.  Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells , 2005, British Journal of Cancer.

[20]  P. Hersey,et al.  The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. , 2004, Molecular cancer therapeutics.

[21]  P. Hersey,et al.  The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. , 2003, Biochemical pharmacology.

[22]  J. Hald,et al.  Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. , 2003, Developmental biology.

[23]  Herb Chen,et al.  Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[24]  W. Pear,et al.  Notch and cancer: best to avoid the ups and downs. , 2003, Cancer cell.

[25]  Horst Hameister,et al.  SHARP is a novel component of the Notch/RBP‐Jκ signalling pathway , 2002 .

[26]  J. Aster,et al.  Notch Signaling in Cancer , 2002, Cancer biology & therapy.

[27]  D. Bernhard,et al.  The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[29]  P. Becker,et al.  The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition , 2001, EMBO reports.

[30]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[31]  D. Ball,et al.  Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. , 1998, Annals of surgery.

[32]  S. Baylin,et al.  Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  S. Baylin,et al.  Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Horst Hameister,et al.  SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. , 2002, The EMBO journal.